A comprehensive review in 3 Biotech details how plant-derived compounds such as polyphenols, flavonoids, and alkaloids can inhibit the toxic protein aggregation driving Alzheimer's and Parkinson's diseases, while outlining medicinal chemistry and nanotechnology strategies to overcome their bioavailability limitations.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.